LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
32.46
-0.19 (-0.57%)
At close: Jun 30, 2026, 4:00 PM EDT
32.46
0.00 (0.00%)
After-hours: Jun 30, 2026, 4:05 PM EDT
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $930.7 million as of June 30, 2026.
Market Cap
930.70M
Enterprise Value
568.53M
1-Year Change
n/a
Ranking
Category
Stock Price
$32.46
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $930.70M, an increase of 208.69%. That is a compound annual growth rate of 309.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 930.70M | 65.26% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 960.32M |
| Avalo Therapeutics | 956.69M |
| Alto Neuroscience | 948.94M |
| Pharming Group | 939.20M |
| Solid Biosciences | 914.60M |
| Janux Therapeutics | 911.11M |
| Theravance Biopharma | 908.88M |
| Evommune | 906.94M |